Cargando…

Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study

OBJECTIVES: To investigate whether the adherens junction protein vascular endothelial cadherin (VE-cadherin) is released during Shiga toxin 2 producing Escherichia coli (STEC) infection with haemolytic uraemic syndrome (HUS) and thus could be used to assist diagnosis. DESIGN: Using data from the lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Doulgere, Julia, Otto, Benjamin, Nassour, Maher, Wolters-Eisfeld, Gerrit, Rohde, Holger, Magnus, Tim, Wagener, Christoph, Streichert, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360836/
https://www.ncbi.nlm.nih.gov/pubmed/25757942
http://dx.doi.org/10.1136/bmjopen-2014-005659
_version_ 1782361593297764352
author Doulgere, Julia
Otto, Benjamin
Nassour, Maher
Wolters-Eisfeld, Gerrit
Rohde, Holger
Magnus, Tim
Wagener, Christoph
Streichert, Thomas
author_facet Doulgere, Julia
Otto, Benjamin
Nassour, Maher
Wolters-Eisfeld, Gerrit
Rohde, Holger
Magnus, Tim
Wagener, Christoph
Streichert, Thomas
author_sort Doulgere, Julia
collection PubMed
description OBJECTIVES: To investigate whether the adherens junction protein vascular endothelial cadherin (VE-cadherin) is released during Shiga toxin 2 producing Escherichia coli (STEC) infection with haemolytic uraemic syndrome (HUS) and thus could be used to assist diagnosis. DESIGN: Using data from the large 2011 STEC outbreak in northern Europe, we determined VE-cadherin plasma concentrations in 356 patients distributed over three patient cohorts: patients with STEC infection accompanied by HUS (STEC-HUS), STEC patients without HUS (STEC) and control patients with diarrhoea but without STEC infection. We then looked for associations between VE-cadherin concentrations and disease severity defined by changes in lactate dehydrogenase, haemoglobin, creatinine, platelet count, haptoglobin and neurological symptoms. SETTING: This study was conducted at the University Medical Center Hamburg-Eppendorf, Germany. PARTICIPANTS: 79 STEC-HUS patients, 77 STEC patients and 200 control patients were enrolled in the study. RESULTS: We analysed 864 specimens (207 STEC, 449 STEC-HUS and 208 controls) in total. At admission, VE-cadherin concentration tended to be lower in STEC-HUS patients compared to other patients. However, HUS patients later showed an increase in VE-cadherin concentrations with prolonged elevation beyond remission. This pattern clearly differs from that observed in non-HUS patients. CONCLUSIONS: VE-cadherin concentrations are elevated in STEC-HUS patients and might be a biomarker reflecting endothelial damage in patients with HUS.
format Online
Article
Text
id pubmed-4360836
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43608362015-03-25 Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study Doulgere, Julia Otto, Benjamin Nassour, Maher Wolters-Eisfeld, Gerrit Rohde, Holger Magnus, Tim Wagener, Christoph Streichert, Thomas BMJ Open Infectious Diseases OBJECTIVES: To investigate whether the adherens junction protein vascular endothelial cadherin (VE-cadherin) is released during Shiga toxin 2 producing Escherichia coli (STEC) infection with haemolytic uraemic syndrome (HUS) and thus could be used to assist diagnosis. DESIGN: Using data from the large 2011 STEC outbreak in northern Europe, we determined VE-cadherin plasma concentrations in 356 patients distributed over three patient cohorts: patients with STEC infection accompanied by HUS (STEC-HUS), STEC patients without HUS (STEC) and control patients with diarrhoea but without STEC infection. We then looked for associations between VE-cadherin concentrations and disease severity defined by changes in lactate dehydrogenase, haemoglobin, creatinine, platelet count, haptoglobin and neurological symptoms. SETTING: This study was conducted at the University Medical Center Hamburg-Eppendorf, Germany. PARTICIPANTS: 79 STEC-HUS patients, 77 STEC patients and 200 control patients were enrolled in the study. RESULTS: We analysed 864 specimens (207 STEC, 449 STEC-HUS and 208 controls) in total. At admission, VE-cadherin concentration tended to be lower in STEC-HUS patients compared to other patients. However, HUS patients later showed an increase in VE-cadherin concentrations with prolonged elevation beyond remission. This pattern clearly differs from that observed in non-HUS patients. CONCLUSIONS: VE-cadherin concentrations are elevated in STEC-HUS patients and might be a biomarker reflecting endothelial damage in patients with HUS. BMJ Publishing Group 2015-03-10 /pmc/articles/PMC4360836/ /pubmed/25757942 http://dx.doi.org/10.1136/bmjopen-2014-005659 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Infectious Diseases
Doulgere, Julia
Otto, Benjamin
Nassour, Maher
Wolters-Eisfeld, Gerrit
Rohde, Holger
Magnus, Tim
Wagener, Christoph
Streichert, Thomas
Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
title Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
title_full Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
title_fullStr Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
title_full_unstemmed Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
title_short Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
title_sort soluble plasma ve-cadherin concentrations are elevated in patients with stec infection and haemolytic uraemic syndrome: a case–control study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360836/
https://www.ncbi.nlm.nih.gov/pubmed/25757942
http://dx.doi.org/10.1136/bmjopen-2014-005659
work_keys_str_mv AT doulgerejulia solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy
AT ottobenjamin solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy
AT nassourmaher solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy
AT wolterseisfeldgerrit solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy
AT rohdeholger solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy
AT magnustim solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy
AT wagenerchristoph solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy
AT streichertthomas solubleplasmavecadherinconcentrationsareelevatedinpatientswithstecinfectionandhaemolyticuraemicsyndromeacasecontrolstudy